Contact Us
Subscribe
E-Edition

64°

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
Sports
Obits
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Subscribe
Archives
Best of 2026

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Monopar Therapeutics Inc. - Common Stock (NQ:MNPR)

59.68 +0.44 (+0.74%)

Streaming Delayed Price Updated: 12:42 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Monopar Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 20, 2024

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

Via Benzinga

Why Is Cancer Drug Focused Monopar Therapeutics Stock Trading Higher On Tuesday? ↗

February 20, 2024

Monopar Therapeutics surges 90% premarket with 3.94 million volume after HREC clearance for Phase 1 dosimetry trial (MNPR-101-Zr) in advanced cancers.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 20, 2024

Via Benzinga

Recap: Monopar Therapeutics Q3 Earnings ↗

November 09, 2023

Via Benzinga

Dow Dips Over 100 Points; US Leading Economic Index Falls In January ↗

February 20, 2024

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 1.5% on Tuesday. The Dow traded down 0.35% to 38,494.51 while the NASDAQ fell 1.51% to 15,537.95. The S&P 500...

Via Benzinga

Topics Stocks

Nasdaq Down 1%; Capital One Set To Buy Discover ↗

February 20, 2024

U.S. stocks traded lower this morning, with the Nasdaq Composite falling around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.05% to 38,607.53 while the NASDAQ fell...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 20, 2024

Via Benzinga

Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers

February 20, 2024

From Monopar Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 12, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 11, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 29, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 06, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 13, 2023

Via Benzinga

Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

November 13, 2023

Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results.

Via Benzinga

Why StoneCo Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket ↗

November 13, 2023

StoneCo Ltd. (NASDAQ: STNE) shares rose in pre-market trading after the company reported upbeat results for its third quarter on Friday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 13, 2023

Via Benzinga

Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent Developments

November 09, 2023

MNPR-101 Radiopharma Program to Enter First-in-Human Studies Potentially As Early As December of This Year Camsirubicin Phase 1b Trial Efficacy and Safety Data Highlighted at the 2023 CTOS Annual...

From Monopar Therapeutics Inc.

Via GlobeNewswire

Why BEST Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

November 06, 2023

Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares surged 358% to $134.37 in pre-market trading after gaining 100% on Friday. The company’s stock began trading on Friday following merger...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

November 03, 2023

It's time to dive into the biggest pre-market stock movers for Friday with all the shares investors will want to keep an eye on today!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 01, 2023

Via Benzinga

Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

November 01, 2023

Gainers

Via Benzinga

Why Is Cancer Focused Monopar Therapeutics Stock Trading Higher Today? ↗

November 01, 2023

Monopar Therapeutics Inc (NASDAQ: MNPR) will present data from its ongoing Phase 1b open-label, dose-escalating trial of camsirubicin in patients with advanced soft tissue sarcoma later today at the...

Via Benzinga

US Stocks Mixed; Private Sector Payrolls Increase Less Than Expected ↗

November 01, 2023

U.S. stocks traded mixed this morning, ahead of interest rate decision from the Federal Reserve. Following the market opening Wednesday, the Dow traded down 0.05% to 33,036.63 while the NASDAQ rose...

Via Benzinga

Topics Economy Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 01, 2023

Via Benzinga

Monopar Presents Data Showing Tumor Reduction Benefit of Camsirubicin from Ongoing Phase 1b at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting

November 01, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

Monopar to Participate in the Roth MKM 2023 Healthcare Opportunities Conference

October 10, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

Monopar to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

September 05, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

Monopar Therapeutics Reports Second Quarter 2023 Financial Results and Recent Developments

August 10, 2023

From Monopar Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 09, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

starkvilledailynews.com
304 E. Lampkin Street,
Starkville, MS 39759
Phone: 662-323-1642
Email: editor@starkvilledailynews.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Monopar Therapeutics Inc. - Common Stock (NQ:MNPR)

All News about Monopar Therapeutics Inc. - Common Stock

Sections

Services

Follow Us